Category: BDN LinkedIn

Lev Facher writes in STAT that the Trump administration on Monday unveiled a “blueprint” to increase capacity for coronavirus tests […]

Read More… from Trump hopes for 2 million tests per week by end of May — the low end of experts’ estimates of what’s needed to reopen

Sharon Begley writes in STAT that more than half of U.S. states will have to significantly step up their Covid-19 […]

Read More… from Many states are far short of Covid-19 testing levels needed for safe reopening, new analysis shows

Sue Halpern writing in The New Yorker asks whether Americans will allow the government to track them via their phones, […]

Read More… from Can We Track COVID-19 and Protect Privacy at the Same Time?

Lois Privor-Dumm, Naor Bar-Zeev and Maria Deloria Knoll of the Johns Hopkins Bloomberg School of Public Health write in STAT […]

Read More… from The success of a Covid-19 vaccine will hinge on its delivery

Charles Duhigg writes in the New Yorker that the first diagnosis of the coronavirus in the United States occurred in […]

Read More… from Seattle’s Leaders Let Scientists Take the Lead. New York’s Did Not

Jaewon Ryu and Karen M. Murphy write in STAT that the biomedical community works to develop treatments and vaccines for […]

Read More… from Public-private partnerships for contact tracing can help stop Covid-19

Caroline Schulman writes in STAT that part of her work as an emergency medicine resident, she began a rotation in […]

Read More… from It was my job to call people whose Covid-19 tests were positive. That taught me a lot about medicine, the law, and society

Colin Dwyer reports on NPR that the World Health Organization has pushed back against the theory that individuals can only […]

Read More… from ‘No Evidence’ That Recovered COVID-19 Patients Are Immune, WHO Says

Brett Samuels writes in The Hill that health experts on the White House coronavirus task force increasingly are being put […]

Read More… from Trump coronavirus briefings put health officials in bind

STAT’s Nicholas Florko takes a long hard look at why Rick Bright, a bureaucrat at an obscure federal agency, burst onto […]

Read More… from Why was an obscure federal bureaucrat involved in Trump’s emergency hydroxychloroquine authorization?